Status:
COMPLETED
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Meningioma
Eligibility:
All Genders
18+ years
Brief Summary
Meningioma, an extra-axial brain tumor developed at the expense of meninges, accounts for 35% of central nervous system tumors, and its incidence is estimated at 3% in large autopsy series. The curre...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient performing MRI as part of a screening or follow-up of known meningioma
- Express consent to participate in the study
Exclusion
- Contraindication for MRI (electrical device, metallic foreign body, claustrophobia)
- Known hypersensitivity to the contrast medium (Gadolinium)
- Known renal failure: glomerular filtration rate \<30mL/min
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
December 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2025
Estimated Enrollment :
514 Patients enrolled
Trial Details
Trial ID
NCT04113395
Start Date
December 23 2019
End Date
July 18 2025
Last Update
January 5 2026
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Grenoble
Grenoble, Grenoble, France, 38100
2
CHU de Limoges
Limoges, Limoges, France, 87042
3
CHU de Lyon
Lyon, Lyon, France, 69495
4
CHU de Nantes
Nantes, Nantes, France, 44800